首站-论文投稿智能助手
典型文献
LncRNA-6395 promotes myocardial ischemia-reperfusion injury in mice through increasing p53 pathway
文献摘要:
Myocardial ischemia-reperfusion(I/R)injury is a pathological process characterized by cardiomyocyte apoptosis,which leads to cardiac dysfunction.Increasing evidence shows that abnormal expression of long noncoding RNAs(IncRNAs)plays a crucial role in cardiovascular diseases.In this study we investigated the role of IncRNAs in myocardial l/R injury.Myocardial I/R injury was induced in mice by ligating left anterior descending coronary artery for 45 min followed by reperfusion for 24 h.We showed that IncRNA KnowTID_00006395,termed IncRNA-6395 was significantly upregulated in the infarct area of mouse hearts following I/R injury as well as in H2O2-treated neonatal mouse ventricular cardiomyocytes(NMVCs).Overexpression of IncRNA-6395 led to cell apoptosis and the expression change of apoptosis-related proteins in NMVCs,whereas knockdown of lncRNA-6395 attenuated H2O2-induced cell apoptosis.LncRNA-6395 knockout mice(IncRNA-6395+/-)displayed improved cardiac function,decreased plasma LDH activity and infarct size following I/R injury.We demonstrated that IncRNA-6395 directly bound to p53,and increased the abundance of p53 protein through inhibiting ubiquitination-mediated p53 degradation and thereby facilitated p53 translocation to the nucleus.More importantly,overexpression of p53 canceled the inhibitory effects of IncRNA-6395 knockdown on cardiomyocyte apoptosis,whereas knockdown of p53 counteracted the apoptotic effects of lncRNA-6395 in cardiomyocytes.Taken together,IncRNA-6395 as an endogenous pro-apoptotic factor,regulates cardiomyocyte apoptosis and myocardial l/R injury by inhibiting degradation and promoting sub-cellular translocation of p53.
文献关键词:
作者姓名:
Lin-feng Zhan;Qi Zhang;Lu Zhao;Xue Dong;Xin-yu Pei;Li-Ii Peng;Xiao-wen Zhang;Bo Meng;Wen-di Shang;Zhen-wei Pan;Chao-qian Xu;Yan-jie Lu;Ming-yu Zhang
作者机构:
Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Medicine Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;China Northern Translational Medicine Research and Cooperation Center,Heilongjiang Academy of Medical Sciences,Harbin Medical University,Harbin 150081,China
引用格式:
[1]Lin-feng Zhan;Qi Zhang;Lu Zhao;Xue Dong;Xin-yu Pei;Li-Ii Peng;Xiao-wen Zhang;Bo Meng;Wen-di Shang;Zhen-wei Pan;Chao-qian Xu;Yan-jie Lu;Ming-yu Zhang-.LncRNA-6395 promotes myocardial ischemia-reperfusion injury in mice through increasing p53 pathway)[J].中国药理学报(英文版),2022(06):1383-1394
A类:
KnowTID,6395+
B类:
LncRNA,promotes,myocardial,ischemia,reperfusion,injury,mice,through,increasing,p53,pathway,Myocardial,pathological,process,characterized,apoptosis,which,leads,cardiac,dysfunction,Increasing,evidence,shows,that,abnormal,long,noncoding,IncRNAs,plays,crucial,role,cardiovascular,diseases,this,study,investigated,was,induced,ligating,left,anterior,descending,coronary,artery,followed,We,showed,termed,significantly,upregulated,infarct,area,mouse,hearts,following,well,H2O2,treated,neonatal,ventricular,cardiomyocytes,NMVCs,Overexpression,change,related,proteins,whereas,knockdown,lncRNA,attenuated,knockout,displayed,improved,decreased,plasma,LDH,activity,size,demonstrated,directly,bound,increased,abundance,inhibiting,ubiquitination,mediated,degradation,thereby,facilitated,translocation,nucleus,More,importantly,overexpression,canceled,inhibitory,effects,counteracted,apoptotic,Taken,together,endogenous,regulates,promoting,sub,cellular
AB值:
0.515675
相似文献
Propofol postconditioning ameliorates hypoxia/reoxygenation induced H9c2 cell apoptosis and autophagy via upregulating forkhead transcription factors under hyperglycemia
Rong‑Hui Han;He‑Meng Huang;Hong Han;Hao Chen;Fei Zeng;Xiang Xie;Dan‑Yong Liu;Yin Cai;Liang‑Qing Zhang;Xin Liu;Zheng‑Yuan Xia;Jing Tang-Department of Anesthesiology,Affiliated Hospital of Guangdong Medical University,57 South Renming Avenue Xiashan District,Zhanjiang 524000,Guangdong,China;Department of Emergency,Affiliated Hospital of Guangdong Medical University,Zhanjiang 524000,Guangdong,China;Department of Anesthesiology,the Eighth Affiliated Hospital,Sun Yat-Sen University,Guangzhou 518000,China;Department of Anesthesiology,Guangzhou First People's Hospital,the Second Affiliated Hospital of South China University of Technology,Guangzhou 510000,China;Department of Anesthesiology,the Second Affiliated Hospital and Yuying Children's Hospital,Wenzhou Medical University,Wenzhou 325000,Zhejiang,China;Department of Health Technology and Informatics,the Hong Kong Polytechnic University,Hung Hom 999077,Hong Kong SAR,China;State Key Laboratory of Pharmaceutical Biotechnology,Department of Medicine,the University of Hong Kong,Pok Fu Lam 999077,Hong Kong SAR,China
The mechanosensitive IncRNA Neat1 promotes osteoblast function through paraspeckle-dependent Smurf1 mRNA retention
Caizhi Liu;Xingcheng Gao;Yuheng Li;Weijia Sun;Youjia Xu;Yingjun Tan;Ruikai Du;Guohui Zhong;Dingsheng Zhao;Zizhong Liu;Xiaoyan Jin;Yinlong Zhao;Yinbo Wang;Xinxin Yuan;Junjie Pan;Guodong Yuan;Youyou Li;Wenjuan Xing;Guanghan Kan;Yanqing Wang;Qi Li;Xuan Han;Jianwei Li;Shukuan Ling;Yingxian Li-State Key Laboratory of Space Medicine Fundamentals and Application,China Astronaut Research and Training Center,Beijing,China;The Key Laboratory of Aerospace Medicine,Ministry of Education,The Fourth Military Medical University,Xi'an,Shaanxi,China;The Second Affiliated Hospital of Soochow University,Suzhou,Jiangsu,China;College of Life Sciences,Hebei Normal University,Shijiazhuang,Hebei,China;Medical College of Soochow University,Suzhou,Jiangsu,China;Medical School of Southeast University,Nanjing,Jiangsu,China
Cardioprotective mechanism of SGLT2 inhibitor against myocardial infarction is through reduction of autosis
Kai Jiang;Yue Xu;Dandan Wang;Feng Chen;Zizhuo Tu;Jie Qian;Sheng Xu;Yixiang Xu;John Hwa;Jian Li;Hongcai Shang;Yaozu Xiang-Shanghai East Hospital,School of Life Sciences and Technology,Tongji University,Shanghai 200092,China;State Key Laboratory of Bioreactor Engineering,Shanghai Key Laboratory of New Drug Design,East China University of Science and Technology,Shanghai 200237,China;Section of Cardiovascular Medicine,Department of Internal Medicine,Yale Cardiovascular Research Center,Yale University School of Medicine,New Haven,CT 06511,USA;Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing,Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine,Beijing 100700,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。